This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Precigen, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Jeffrey Gentry
Introduction
Jeffrey Gentry is an accomplished inventor based in Boulder, CO (US). He has made significant contributions to the field of biotechnology, particularly through his innovative work on electroporation technology. His inventions have the potential to enhance the delivery of therapeutic agents into cells, which is crucial for various medical applications.
Latest Patents
One of Jeffrey Gentry's notable patents is for an "Electroporation apparatus and method." This patent describes a technique where an electrical field is applied to cells to increase the permeability of the cell membrane. This process allows for the introduction of chemicals, drugs, and macromolecules such as proteins and nucleic acids into the cells. The electroporation apparatus comprises multiple chambers designed to store cells during the electroporation process, electrodes to generate electric fields, a flow channel for transporting cells post-process, and valves connecting the chambers to the flow channel. Jeffrey holds 1 patent in this area.
Career Highlights
Jeffrey Gentry is currently associated with Precigen, Inc., a company focused on advancing the field of biotechnology. His work at Precigen has allowed him to explore innovative solutions that can significantly impact medical treatments and therapies.
Collaborations
Throughout his career, Jeffrey has collaborated with talented individuals such as Shuyuan Zhang and Chad B Green. These collaborations have fostered a creative environment that encourages the development of groundbreaking technologies.
Conclusion
Jeffrey Gentry's contributions to electroporation technology exemplify the innovative spirit of modern inventors. His work not only advances scientific understanding but also holds promise for future medical breakthroughs.